RESULTS OF CLINICAL STUDIES WITH CAPREOMYCIN, ETHAMBUTOL AND RIFAMPICIN IN HECKESHORN HOSPITAL, BERLIN

被引：0
|
作者：
RADENBAV.KL
机构：
来源：
SCANDINAVIAN JOURNAL OF RESPIRATORY DISEASES | 1969年 / S卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：43 / &
相关论文
共 50 条
  • [21] RIFAMPICIN, ISONIAZID, ETHAMBUTOL, ETHIONAMIDE, AND STREPTOMYCIN IN MURINE TUBERCULOSIS - COMPARATIVE CHEMOTHERAPEUTIC STUDIES
    KRADOLFER, F
    ANTIBIOTICA ET CHEMOTHERAPIA, 1970, 16 : 352 - +
  • [22] Feasibility of the GenoType MTBDRsl Assay for Fluoroquinolone, Amikacin-Capreomycin, and Ethambutol Resistance Testing of Mycobacterium tuberculosis Strains and Clinical Specimens
    Hillemann, Doris
    Ruesch-Gerdes, Sabine
    Richter, Elvira
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (06) : 1767 - 1772
  • [23] EXPERIMENTAL AND CLINICAL STUDIES ON RIFAMPICIN IN TREATMENT OF LEPROSY
    REES, RJW
    PEARSON, JMH
    WATERS, MFR
    BRITISH MEDICAL JOURNAL, 1970, 1 (5688): : 89 - &
  • [24] MYCOBACTERIUM-KANSASII PULMONARY INFECTION - A PROSPECTIVE-STUDY OF THE RESULTS OF 9 MONTHS OF TREATMENT WITH RIFAMPICIN AND ETHAMBUTOL
    JENKINS, PA
    BANKS, J
    CAMPBELL, IA
    SMITH, AP
    AGNEW, RAL
    ANDERSON, BP
    AYRES, JG
    BAGG, LR
    BANKS, RA
    BARBER, PV
    BARNES, P
    BASRAN, G
    BATEMAN, JRM
    BELL, R
    BENSON, MK
    BLAINEY, AD
    BOSS, G
    BHOOMKAR, AM
    BRENNAN, SR
    BRITTON, MG
    BURTON, AL
    CALVERLEY, P
    CAMERON, IR
    CATTERALL, J
    CHAPPELL, AG
    CHARLES, TJ
    CHOPRA, MP
    CLAGUE, HW
    CLARKE, CJ
    COHEN, H
    COCHRANE, GM
    COPPER, DN
    COSTELLO, JF
    COTTON, SG
    COURTNEY, ERJ
    DAVIES, D
    DAVIES, RJ
    DENT, RG
    DUFFY, M
    EARIS, JE
    ELLIS, DA
    ELLIS, M
    ELLIS, RH
    ERAUT, CD
    EVANS, CC
    EVANS, WV
    FERGUSON, CG
    GILLINGS, M
    HAWKES, RA
    HEAF, PJD
    THORAX, 1994, 49 (05) : 442 - 445
  • [25] On the strumous results in the mortuary of Charite hospital in Berlin.
    Staemmler, M
    VIRCHOWS ARCHIV FUR PATHOLOGISCHE ANATOMIE UND PHYSIOLOGIE UND FUR KLINISCHE MEDIZIN, 1914, 217 (02): : 184 - 204
  • [26] Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance
    van Ingen, Jakko
    Hoefsloot, Wouter
    Mouton, Johan W.
    Boeree, Martin J.
    van Soolingen, Dick
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (01) : 80 - 82
  • [27] LONG-TERM RESULTS WITH RIFAMPICIN TOGETHER WITH ETHAMBUTOL AND/OR OTHER DRUGS IN TREATMENT OF TUBERCULOSIS WITH CULTURES RESISTANT TO STANDARD DRUGS
    PINES, A
    RESPIRATION, 1971, 28 : 91 - &
  • [28] CONTROLLED TRIAL OF DAILY AND INTERMITTENT RIFAMPICIN PLUS ETHAMBUTOL IN RETREATMENT OF PATIENTS WITH PULMONARY TUBERCULOSIS - RESULTS UP TO 30 MONTHS
    不详
    TUBERCLE, 1975, 56 (03): : 179 - 189
  • [29] TREATMENT OF NEW CASES OF PULMONARY TUBERCULOSIS WITH A COMBINATION OF ISOPRODIAN AND ETHAMBUTOL - CLINICAL RESULTS
    OPL, G
    BENKO, M
    PRAXIS DER PNEUMOLOGIE, 1977, 31 (02): : 116 - 120
  • [30] Clinical results of intestinal and multivisceral transplantation at the Charite, Berlin
    Pascher, A
    Klupp, J
    Schulz, RJ
    Kohler, S
    Junge, G
    Sauer, IM
    Veltzke-Schlieker, W
    Adler, A
    Guckelberger, O
    Nüssler, NC
    Dignass, A
    Langrehr, JM
    Neuhaus, P
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (08) : 387 - 392
12345